Migdal Insurance & Financial Holdings’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37K | Buy |
344
+145
| +73% | +$15.6K | ﹤0.01% | 278 |
|
|
2025
Q1 | $20K | Buy |
+199
| New | +$20K | ﹤0.01% | 346 |
|
|
2024
Q4 | – | Sell |
-8
| Closed | -$1K | – | 363 |
|
|
2024
Q3 | $1K | Sell |
8
-466
| -98% | -$58.3K | ﹤0.01% | 400 |
|
|
2024
Q2 | $37K | Buy |
+474
| New | +$37K | ﹤0.01% | 321 |
|
|
2021
Q2 | – | Sell |
-703
| Closed | -$27K | – | 597 |
|
|
2021
Q1 | $27K | Buy |
703
+648
| +1,178% | +$24.9K | ﹤0.01% | 594 |
|
|
2020
Q4 | $2K | Sell |
55
-23,806
| -100% | -$866K | ﹤0.01% | 637 |
|
|
2020
Q3 | $912K | Sell |
23,861
-20,677
| -46% | -$790K | 0.01% | 305 |
|
|
2020
Q2 | $1.56M | Buy |
44,538
+14,529
| +48% | +$510K | 0.03% | 209 |
|
|
2020
Q1 | $979K | Buy |
30,009
+2,346
| +8% | +$76.5K | 0.02% | 180 |
|
|
2019
Q4 | $1.25M | Buy |
27,663
+3,838
| +16% | +$174K | 0.02% | 190 |
|
|
2019
Q3 | $969K | Buy |
23,825
+7,129
| +43% | +$290K | 0.02% | 251 |
|
|
2019
Q2 | $718K | Buy |
16,696
+4,841
| +41% | +$208K | 0.02% | 282 |
|
|
2019
Q1 | $455K | Buy |
+11,855
| New | +$455K | 0.01% | 317 |
|
|
2018
Q4 | – | Sell |
-12,330
| Closed | -$475K | – | 708 |
|
|
2018
Q3 | $475K | Buy |
12,330
+8,310
| +207% | +$320K | 0.01% | 385 |
|
|
2018
Q2 | $131K | Buy |
4,020
+3,894
| +3,090% | +$127K | ﹤0.01% | 473 |
|
|
2018
Q1 | $3K | Buy |
+126
| New | +$3K | ﹤0.01% | 588 |
|